AMCAD BIOMED CORPORATION AmCad BioMed Corporation Share Price
Equities
4188
TW0004188008
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.85 TWD | -1.47% |
|
-1.10% | +0.56% |
| Sales 2022 | 61.63M 1.91M 152M | Sales 2023 | 65.26M 2.02M 161M | Capitalization | 1.42B 44.06M 3.51B |
|---|---|---|---|---|---|
| Net income 2022 | -53M -1.64M -131M | Net income 2023 | -45M -1.39M -111M | EV / Sales 2022 | 8.57 x |
| Net cash position 2022 | 321M 9.93M 791M | Net cash position 2023 | 273M 8.45M 673M | EV / Sales 2023 | 17.6 x |
| P/E ratio 2022 |
-15.9
x | P/E ratio 2023 |
-31.4
x | Employees | 34 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 46.49% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -1.47% | ||
| 1 week | -1.10% | ||
| Current month | -0.19% | ||
| 1 month | -8.83% | ||
| 3 months | -18.64% | ||
| 6 months | -2.54% | ||
| Current year | +0.56% |
1 week
26.70
28.15
1 month
23.9529.20
Current year
23.9537.40
1 year
15.8537.40
3 years
14.2037.40
5 years
11.2537.40
10 years
11.2563.99
| Managers | Title | Age | Since |
|---|---|---|---|
Yi Li Lee
CEO | Chief Executive Officer | 53 | 05/05/11 |
Chih-Yuan Huang
DFI | Director of Finance/CFO | - | - |
Chun Hsiang Yang
CTO | Chief Tech/Sci/R&D Officer | - | 02/05/10 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wen Hua Chen
BRD | Director/Board Member | - | 05/05/11 |
Yue Ju Lai
BRD | Director/Board Member | - | 05/05/11 |
Kuan Chih Chen
BRD | Director/Board Member | - | 05/05/11 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/05/24 | 26.85 | -1.47% | 68,165 |
| 02/05/24 | 27.25 | +1.30% | 164,246 |
| 30/04/24 | 26.9 | -0.37% | 97,150 |
| 29/04/24 | 27 | -0.55% | 95,200 |
| 26/04/24 | 27.15 | +0.18% | 126,504 |
End-of-day quote Taipei Exchange, May 02, 2024
More quotes
AmCad BioMed Corporation is a Taiwan-based company principally engaged in the research, development and manufacture of computer-aided diagnosis (CAD) medical equipment. The Companyâs products include AmCAT-UT Dection, which is a computer-aided detection system of thyroid ultrasound, and AmCAD-UT Diagnosis, which is a computer-aided diagnosis system of thyroid ultrasound. The Company operates in Taiwan, China and Hong Kong markets.
| 1st Jan change | Capi. | |
|---|---|---|
| +0.56% | 44.33M | |
| -42.33% | 2.84B | |
| +17.00% | 1.85B | |
| -0.51% | 1.66B | |
| +27.15% | 1.26B | |
| -13.90% | 989M | |
| -21.76% | 896M | |
| -2.72% | 757M | |
| -23.95% | 633M | |
| +6.84% | 500M |
- Stock Market
- Equities
- 4188 Stock
